Role of long-acting cephalosporins in the treatment of lower respiratory tract infections

Clin Microbiol Infect. 2000:6 Suppl 3:87-9. doi: 10.1111/j.1469-0691.2000.tb02054.x.
No abstract available

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Cefotaxime / administration & dosage
  • Cefotaxime / pharmacokinetics
  • Cefotaxime / therapeutic use*
  • Ceftriaxone / adverse effects
  • Ceftriaxone / pharmacokinetics
  • Ceftriaxone / therapeutic use*
  • Cephalosporins / administration & dosage
  • Cephalosporins / pharmacokinetics
  • Cephalosporins / therapeutic use*
  • Female
  • Gram-Negative Bacterial Infections / drug therapy*
  • Gram-Negative Bacterial Infections / microbiology
  • Humans
  • Male
  • Middle Aged
  • Randomized Controlled Trials as Topic
  • Respiratory Tract Infections / drug therapy*
  • Respiratory Tract Infections / microbiology

Substances

  • Cephalosporins
  • Ceftriaxone
  • Cefotaxime